Intellia Therapeutics, Inc. (NTLA)
NASDAQ·Healthcare·Biotechnology
$11.23
+4.18%
Mkt Cap $1.22B
Analyst Ratings
Buy
12
Hold
6
Sell
2
Price Target (55 analysts)
$23.50
Range $9.00 – $49.00
Implied Upside
+109.3%
Consensus $23.50 vs current $11.23
NASDAQ·Healthcare·Biotechnology
$11.23
+4.18%
Mkt Cap $1.22B
Buy
12
Hold
6
Sell
2
Price Target (55 analysts)
$23.50
Range $9.00 – $49.00
+109.3%
Consensus $23.50 vs current $11.23